Survival in blacks and whites after treatment for localized prostate cancer
Survival in blacks and whites after treatment for localized prostate cancer
复制标题
DOI：
10.1016/s0022-5347(01)65966-4
复制
发表时间：
1996-07-01
影响因子：
6.6
通讯作者：
Terrell, F
中科院分区：
文献类型：
--
作者：
Fowler, JE;Terrell, F
目的：评估局部前列腺癌治疗后所有病因和疾病相关的精算生存率的种族差异。材料和方法：我们研究了148名黑人和209名白人男性的临床分期为T1b到4NXMO的前列腺癌。结果：经过96个月的中位随访期，109名黑人和167名白人男性的T1b到T1b期前列腺癌接受手术或放射治疗后的全原因、原因特定、无转移、临床无病或前列腺特异性抗原无病生存期无显著差异。39名黑人和42名白人男性的T3至4期癌症接受放射治疗。结论：种族似乎不影响在平等机会的医疗保健系统中接受手术或放射治疗的局限性前列腺癌患者的特定阶段精算生存率。
Purpose: Racial differences were assessed in all cause and disease related actuarial survivals after treatment for localized prostate cancer.Materials and Methods: We studied 148 black and 209 white men with clinical stages T1b to 4NXMO prostate cancer treated with surgery or radiation therapy between 1980 and 1991 at a Veterans Affairs medical center.Results: After a median potential followup of 96 months, there were no significant differences in the all cause, cause specific, metastases-free, clinical disease-free or prostate specific antigen disease-free survivals in 109 black and 167 white men with stages T1b to 2 cancer treated with surgery or radiation therapy, or in 39 black and 42 white men with stages T3 to 4 cancer treated with radiation therapy.Conclusions: Race appears to have no impact on the stage specific actuarial survivals in men with localized prostate cancer treated with surgery or radiation therapy in an equal access health care system.